Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Sep 26;10(27):9921-9928.
doi: 10.12998/wjcc.v10.i27.9921.

Concurrent severe hepatotoxicity and agranulocytosis induced by Polygonum multiflorum: A case report

Affiliations
Case Reports

Concurrent severe hepatotoxicity and agranulocytosis induced by Polygonum multiflorum: A case report

You-Lin Shao et al. World J Clin Cases. .

Abstract

Background: Various types of drug-induced liver injury are induced by Polygonum multiflorum (PM); however, it rarely causes neutropenia. Herein, we report the case of a 65-year-old woman with concurrent severe hepatotoxicity and agranulocytosis induced by PM.

Case summary: A 65-year-old woman reported with severe hepatotoxicity and agranulocytosis 17 d after ingestion of PM. The results of the Roussel Uclaf Causality Assessment Method demonstrated a highly probable relationship between hepatotoxicity and PM, with a total score of 10. The Naranjo algorithm results indicated that agranulocytosis had a probable relationship with PM, with an overall score of 6. Granulocyte colony-stimulating factor (for once), a steroid, compound glycyrrhizin, and polyene phosphatidylcholine therapy were initiated. After 15 d of treatment, there was a gradual improvement in liver biochemistry, leukocytes, and neutrophils levels.

Conclusion: Concurrent hepatotoxicity and agranulocytosis are rare and critical adverse drug reactions of PM, which should be highly valued.

Keywords: Agranulocytosis; Case report; Hepatotoxicity; Polygonum multiflorum.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Figures

Figure 1
Figure 1
Microscopic view of bone marrow aspirate showing severe agranulocytosis. A: A neutrophilic myelocyte; B: A neutrophilic myelocyte and a promyelocyte.
Figure 2
Figure 2
Clinical course of the patient. A: Changes in levels of alanine aminotransferase, aspartate aminotransferase, and total bilirubin; B: Changes in the count of leukocytes, neutrophils, and lymphocytes. TBIL: Total bilirubin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase.

Similar articles

References

    1. Lin L, Ni B, Lin H, Zhang M, Li X, Yin X, Qu C, Ni J. Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: a review. J Ethnopharmacol. 2015;159:158–183. - PMC - PubMed
    1. Ballotin VR, Bigarella LG, Brandão ABM, Balbinot RA, Balbinot SS, Soldera J. Herb-induced liver injury: Systematic review and meta-analysis. World J Clin Cases. 2021;9:5490–5513. - PMC - PubMed
    1. But PP, Tomlinson B, Lee KL. Hepatitis related to the Chinese medicine Shou-wu-pian manufactured from Polygonum multiflorum. Vet Hum Toxicol. 1996;38:280–282. - PubMed
    1. Rao T, Liu YT, Zeng XC, Li CP, Ou-Yang DS. The hepatotoxicity of Polygonum multiflorum: The emerging role of the immune-mediated liver injury. Acta Pharmacol Sin. 2021;42:27–35. - PMC - PubMed
    1. Rattay B, Benndorf RA. Drug-Induced Idiosyncratic Agranulocytosis - Infrequent but Dangerous. Front Pharmacol. 2021;12:727717. - PMC - PubMed

Publication types